what does lyka labs do

Lyka Labs Limited is a pharmaceutical company that develops, manufactures, and markets generic finished dosage forms. It focuses on quality pharmaceutical products and operates in India.

what products does lyka labs make

Lyka Labs produces generic pharmaceutical products, including various finished dosage forms, though specific product details are not provided in the context.

what sector is lyka labs in

Lyka Labs operates in the pharmaceutical sector, specifically in the manufacturing and marketing of generic medicines.

when was lyka labs founded

Lyka Labs was established in 2000, as per the provided web information, though the company's history mentions incorporation in 1976 for a related entity.

Lyka Labs is a publicly listed company on the BSE and NSE, with ownership dispersed among shareholders, though specific details are not provided in the context.

Lyka Labs Limited (LYKALABS) Share Price Today — ₹57.56

Lyka Labs Limited (LYKALABS) live stock price is ₹57.56. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Lyka Labs Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Lyka Labs Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

LYKALABS

BSE

Lyka Labs Limited

Healthcare· Pharmaceuticals & Biotechnology· INE933A01014· Scrip: 500259

EN हिन्दी ગુજરાતી मराठी

₹57.56

▲ 2.56 (+0.00%)

2026-05-27

BSE

₹57.56

▲ 2.56

+0.00%

243 trading days · 1Y period

TODAY (BSE)

Open57.25

High58.98

Low57.25

Prev Close60.12

Volume2,762

Value₹0.0Cr

L: 57.25H: 58.98

Info

Face Value₹10

Listed1995-02-08

ISININE933A01014

SeriesB

BSE Scrip500259

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-17.88%

PAT+28.98%

EPS+29.31%

Profitability

EBITDA Margin20.4%

Net Margin8.0%

TTM EBITDA M.14.6%

TTM Net M.3.3%

Dividend

Yield—

Latest DPS—

Payout Ratio—

Growth—

TTM Revenue

₹133 Cr

TTM EBITDA

₹19 Cr

TTM PAT

₹4 Cr

TTM EPS

₹-2.01

Rev/Share

₹37.2

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	34 Cr	31 Cr	7 Cr	4 Cr	3 Cr	₹0.75
2024-09-30	41 Cr	39 Cr	6 Cr	3 Cr	2 Cr	₹0.58
2024-06-30	30 Cr	28 Cr	4 Cr	2 Cr	2 Cr	₹0.49
2024-03-31	28 Cr	30 Cr	3 Cr	-2 Cr	-2 Cr	₹-3.83
2023-12-31	33 Cr	30 Cr	9 Cr	3 Cr	2 Cr	₹0.53
2023-09-30	28 Cr	29 Cr	4 Cr	-1 Cr	-1 Cr	₹-0.16
2023-03-31	22 Cr	25 Cr	3 Cr	-3 Cr	-3 Cr	₹-1.05
2022-12-31	18 Cr	22 Cr	-4 Cr	-10 Cr	-11 Cr	₹-3.64

Shareholding Pattern

CURRENT — 2026-03-31

Promoter58.2%

FII0.3%

DII0.7%

Public41.8%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2024-08-01	Other	Annual General Meeting
2023-07-21	Other	Annual General Meeting
2022-07-21	Other	Annual General Meeting
2021-07-22	Other	Annual General Meeting
2020-09-16	Other	Annual General Meeting
2019-09-06	Other	Annual General Meeting
2018-09-19	Other	Annual General Meeting
2017-09-21	Other	Annual General Meeting
2016-09-19	Other	Annual General Meeting
2015-12-22	Other	Annual General Meeting
2014-12-22	Other	Annual General Meeting
2013-09-19	Other	Annual General Meeting
2012-09-26	Other	Annual General Meeting
2011-04-20	Other	Annual General Meeting
2010-03-22	Other	Annual General Meeting
2008-10-07	Other	Annual General Meeting
2007-08-16	Other	Agm Bc Start Date Revised
2006-05-04	Other	Agm
2005-03-17	Other	Agm

Price History

Date	Open	High	Low	Close	Volume
2026-05-27	58.70	60.49	57.03	57.59	67,614
2026-05-26	58.99	61.00	58.65	59.83	1.26L
2026-05-25	62.27	64.00	61.20	61.72	20,509
2026-05-22	62.42	62.42	60.13	61.41	8,672
2026-05-21	61.67	61.91	60.26	61.27	4,052
2026-05-20	60.99	62.20	60.06	60.67	15,273
2026-05-19	58.98	60.90	58.90	59.74	13,013
2026-05-18	60.11	60.30	58.54	58.80	16,924
2026-05-15	62.37	62.37	60.50	61.62	5,438
2026-05-14	61.89	63.74	59.13	62.41	22,896
2026-05-13	61.40	62.89	58.30	62.24	16,149
2026-05-12	63.20	63.20	60.88	61.22	14,685
2026-05-11	66.75	67.99	62.20	64.08	23,963
2026-05-08	62.27	65.38	62.27	65.38	26,774
2026-05-07	59.00	62.47	59.00	62.27	26,520
2026-05-06	59.25	60.00	58.11	59.50	19,237
2026-05-05	57.95	59.25	57.15	58.25	30,798
2026-05-04	59.75	60.00	57.00	57.68	38,872
2026-04-30	60.38	60.38	57.75	59.70	16,362
2026-04-29	60.80	61.20	58.40	60.38	28,562
2026-04-28	58.87	60.00	58.05	59.38	23,039
2026-04-27	57.82	60.30	57.82	58.45	28,796
2026-04-24	60.75	61.00	57.13	57.58	19,675
2026-04-23	59.25	60.65	58.05	59.21	11,047
2026-04-22	59.01	59.80	57.25	59.49	17,899
2026-04-21	60.48	61.00	59.00	59.06	9,761
2026-04-20	59.50	61.25	58.01	58.15	17,345
2026-04-17	58.97	60.50	57.00	59.83	21,569
2026-04-16	57.90	58.50	57.01	57.78	37,459
2026-04-15	58.58	59.80	55.18	56.53	89,482

Frequently Asked Questions

About

Lyka Labs Limited, a prominent Indian pharmaceutical company listed on the NSE and BSE, engages in the development, manufacturing, and marketing of quality finished dosages and active pharmaceutical ingredients. Their key products include pharmaceutical formulations, and the company has been in operation since its incorporation in 1976, establishing itself as a significant player in the healthcare sector.